ClinicalTrials.govpublic full text
Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD
chronic kidney disease in type 2 diabetes, obesity & overweight, chronic kidney disease, cardiovascular disease, obesity, diabetes mellitus, steatosis, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 898601
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.